Effect of Statin Therapy on Mortality in Patients With Ventilator Associated Pneumonia
Status:
Completed
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
Statins with their powerful anti-inflammatory, immunomodulatory, and antioxidant properties
make them candidate members to be used in the management of sepsis and different types of
infections including pneumonia.
This study aims to determine whether adjunctive statin therapy decreased day- 28 mortality
among ICU patients with ventilator-associated pneumonia (VAP) & number of ventilator-free
days (after successful weaning) between day 1 and both day 28.